Patient's Perceptions of the Cannabis-psychosis Link - A Systematic Review

被引:6
作者
Buadze, Anna [2 ]
Kaiser, Stefan [1 ]
Stohler, Rudolf [1 ]
Roessler, Wulf [1 ]
Seifritz, Erich [2 ]
Liebrenz, Michael [2 ]
机构
[1] Univ Zurich, Clin Gen & Social Psychiat, CH-8032 Zurich, Switzerland
[2] Univ Zurich, Clin Affect Disorders & Gen Psychiat, CH-8032 Zurich, Switzerland
关键词
Cannabis; psychosis; link; schizophrenia; perception; subjective view; review; SUBSTANCE USE; VOLUME ABNORMALITIES; ILLNESS PERCEPTIONS; QUALITATIVE METHODS; INSULIN THERAPY; YOUNG-ADULTS; HIGH-RISK; DRUG-USE; SCHIZOPHRENIA; REASONS;
D O I
10.2174/138161212802884645
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past years a growing research effort has investigated the relation between cannabis use and schizophrenia at a neurobiological, epidemiological and clinical level. A number of systematic reviews and meta analyses have summarized the available evidence in the field. Conversely the patient's perception of the link between cannabis use and psychosis has been under investigation. Since patient's beliefs and attitudes strongly correlate with adherence to all forms of treatment, we conducted a systematic PUBMED database search for any English and German-language articles published until January 2012 that addressed patient's perception of a cannabis psychosis link. Six studies including psychotic subjects met inclusion criteria yielding a total sample of 97. The vast majority of patients with either schizophrenia or a recent psychosis disagreed with a causal link between cannabis use and their mental illness. We qualitatively reviewed the explanatory models underlying their views, which were multi-factorial, psychological, social, biological, esoteric and irrational factors. Most patient's believed that the temporal sequence of events did not clearly indicate a causal relationship for them. They thus discarded the hypothesis of a causal link between cannabis use and psychosis. Despite the heterogeneity of the included studies, findings are comparable and support the robustness of this review. Limitations and implications for clinicians and psychosis research are discussed.
引用
收藏
页码:5105 / 5112
页数:8
相关论文
共 92 条
[1]   Reasons for substance use in schizophrenia [J].
Addington, J ;
Duchak, V .
ACTA PSYCHIATRICA SCANDINAVICA, 1997, 96 (05) :329-333
[2]   Changing incidence of psychotic disorders among the young in Zurich [J].
Ajdacic-Gross, Vladeta ;
Lauber, Christoph ;
Warnke, Inge ;
Haker, Helene ;
Murray, Robin M. ;
Roessler, Wulf .
SCHIZOPHRENIA RESEARCH, 2007, 95 (1-3) :9-18
[3]   Can evaluation studies benefit from triangulation? A case study [J].
Ammenwerth, E ;
Iller, C ;
Mansmann, U .
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2003, 70 (2-3) :237-248
[4]   CANNABIS AND SCHIZOPHRENIA - A LONGITUDINAL-STUDY OF SWEDISH CONSCRIPTS [J].
ANDREASSON, S ;
ENGSTROM, A ;
ALLEBECK, P ;
RYDBERG, U .
LANCET, 1987, 2 (8574) :1483-1486
[5]   THE CAUSES OF FUNCTIONAL PSYCHOSES AS SEEN BY PATIENTS AND THEIR RELATIVES .1. THE PATIENTS POINT OF VIEW [J].
ANGERMEYER, MC ;
KLUSMANN, D .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1988, 238 (01) :47-54
[6]  
[Anonymous], PSYCHOL MED
[7]  
[Anonymous], SCHIZOPHRENIA B
[8]  
[Anonymous], HUM BRAIN MAPP
[9]  
[Anonymous], SCHIZOPHRENIA B
[10]  
[Anonymous], SCHIZOPHRENIA RES